CYP4A11 Antibodies

Santa Cruz Biotechnology provides a broad selection of CYP4A11 monoclonal antibodies for research focused on understanding this important enzyme. CYP4A11 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CYP4A11 is a member of the cytochrome P450 family, which plays a crucial role in the metabolism of fatty acids and the synthesis of bioactive lipids. The enzyme actively participates in regulating blood pressure and inflammation, making it significant in cardiovascular health and disease. Research involving CYP4A11 can provide valuable insights into various metabolic disorders and potential therapeutic targets. Scientists worldwide utilize CYP4A11 monoclonal antibodies to advance their understanding of metabolic pathways and disease mechanisms. Ongoing studies of CYP4A11 continue to reveal new aspects of its biological functions and regulatory mechanisms. The exploration of CYP4A11's role in different physiological processes helps identify novel therapeutic approaches for various diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge and therapeutic development in the field of metabolic research.